94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Tatyana Veremeyko1
Amanda W. Y. Yung1
Daniel C. Anthony2
Tatyana Strekalova3,4,5
Eugene D. Ponomarev1,6*- 1Faculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong
- 2Department of Pharmacology, University of Oxford, Oxford, United Kingdom
- 3Department of Neuroscience, Maastricht University, Maastricht, Netherlands
- 4Institute of General Pathology and Pathophysiology, Moscow, Russia
- 5Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia
- 6Kunming Institute of Zoology-Chinese University of Hong Kong Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming, China
A Corrigendum on
Early Growth Response Gene-2 Is Essential for M1 and M2 Macrophage Activation and Plasticity by Modulation of the Transcription Factor CEBPβ
by Veremeyko, T., Yung, A. W. Y., Anthony, D. C., Strekalova, T., and Ponomarev, E. D. (2018). Front. Immunol. 9:2515. doi: 10.3389/fimmu.2018.02515
In the published article, there was an error regarding the affiliation for Tatyana Strekalova. As well as having affiliations 3 and 4, she should also have “Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine and Department of Normal Physiology, Sechenov First Moscow State Medical University, Moscow, Russia”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: CEBPβ, Egr2, M1/M2 balance, activation, inflammation, monocytes/macrophages, plasticity
Citation: Veremeyko T, Yung AWY, Anthony DC, Strekalova T and Ponomarev ED (2018) Corrigendum: Early Growth Response Gene-2 Is Essential for M1 and M2 Macrophage Activation and Plasticity by Modulation of the Transcription Factor CEBPβ. Front. Immunol. 9:2923. doi: 10.3389/fimmu.2018.02923
Received: 27 November 2018; Accepted: 28 November 2018;
Published: 13 December 2018.
Approved by:
Frontiers in Immunology Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2018 Veremeyko, Yung, Anthony, Strekalova and Ponomarev. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Eugene D. Ponomarev, ZXBvbm9tYXJldkBjdWhrLmVkdS5oaw==